Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Risedronate increases osteoblastic differentiation and function through connexin43.

Jeong HM, Jin YH, Choi YH, Chung JO, Cho DH, Chung MY, Civitelli R, Chung DJ, Lee KY.

Biochem Biophys Res Commun. 2013 Mar 1;432(1):152-6. doi: 10.1016/j.bbrc.2013.01.068. Epub 2013 Jan 29.

PMID:
23376077
[PubMed - indexed for MEDLINE]
2.

Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells.

Casado-Díaz A, Santiago-Mora R, Dorado G, Quesada-Gómez JM.

Arch Med Res. 2013 Jul;44(5):325-34. doi: 10.1016/j.arcmed.2013.05.002. Epub 2013 Jul 16.

PMID:
23867791
[PubMed - indexed for MEDLINE]
3.

EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.

Zhu J, Shimizu E, Zhang X, Partridge NC, Qin L.

J Cell Biochem. 2011 Jul;112(7):1749-60. doi: 10.1002/jcb.23094. Erratum in: J Cell Biochem. 2012 Apr;113(4):1448.

PMID:
21381079
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.

Jeong BC, Kim HJ, Bae IH, Lee KN, Lee KY, Oh WM, Kim SH, Kang IC, Lee SE, Koh GY, Kim KK, Koh JT.

Bone. 2010 Feb;46(2):479-86. doi: 10.1016/j.bone.2009.09.019. Epub 2009 Sep 25.

PMID:
19782780
[PubMed - indexed for MEDLINE]
5.

Connexin43 potentiates osteoblast responsiveness to fibroblast growth factor 2 via a protein kinase C-delta/Runx2-dependent mechanism.

Lima F, Niger C, Hebert C, Stains JP.

Mol Biol Cell. 2009 Jun;20(11):2697-708. doi: 10.1091/mbc.E08-10-1079. Epub 2009 Apr 1.

PMID:
19339281
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation.

Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T.

J Biol Chem. 2008 Oct 24;283(43):29119-25. doi: 10.1074/jbc.M801774200. Epub 2008 Aug 14.

PMID:
18703512
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.

Plotkin LI, Lezcano V, Thostenson J, Weinstein RS, Manolagas SC, Bellido T.

J Bone Miner Res. 2008 Nov;23(11):1712-21. doi: 10.1359/jbmr.080617.

PMID:
18597631
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-κB ligand and apoptosis in mesenchymal stem cells.

Fujita H, Kurokawa K, Ogino T, Ono M, Yamamoto M, Oka T, Nakanishi T, Kobayashi N, Tanaka N, Ogawa T, Suzaki E, Utsumi K, Sasaki J.

Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):78-84. doi: 10.1111/j.1742-7843.2011.00685.x. Epub 2011 Mar 16.

PMID:
21332944
[PubMed - indexed for MEDLINE]
9.

Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation.

Ito S, Suzuki N, Kato S, Takahashi T, Takagi M.

Bone. 2007 Jan;40(1):84-92. Epub 2006 Sep 1.

PMID:
16949358
[PubMed - indexed for MEDLINE]
10.

Retinoblastoma binding protein-1 (RBP1) is a Runx2 coactivator and promotes osteoblastic differentiation.

Monroe DG, Hawse JR, Subramaniam M, Spelsberg TC.

BMC Musculoskelet Disord. 2010 May 28;11:104. doi: 10.1186/1471-2474-11-104.

PMID:
20509905
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.

Yonezawa T, Lee JW, Hibino A, Asai M, Hojo H, Cha BY, Teruya T, Nagai K, Chung UI, Yagasaki K, Woo JT.

Biochem Biophys Res Commun. 2011 Jun 3;409(2):260-5. doi: 10.1016/j.bbrc.2011.05.001. Epub 2011 May 6.

PMID:
21570953
[PubMed - indexed for MEDLINE]
12.

Osteoblast proliferation and maturation by bisphosphonates.

Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS.

Biomaterials. 2004 Aug;25(18):4105-15.

PMID:
15046901
[PubMed - indexed for MEDLINE]
13.

Characterization of hTERT-immortalized osteoblast cell lines generated from wild-type and connexin43-null mouse calvaria.

Thi MM, Urban-Maldonado M, Spray DC, Suadicani SO.

Am J Physiol Cell Physiol. 2010 Nov;299(5):C994-C1006. doi: 10.1152/ajpcell.00544.2009. Epub 2010 Aug 4.

PMID:
20686067
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Inhibition of osteoblastic differentiation by warfarin and 18-α-glycyrrhetinic acid.

Jeong HM, Cho DH, Jin YH, Chung JO, Chung MY, Chung DJ, Lee KY.

Arch Pharm Res. 2011 Aug;34(8):1381-7. doi: 10.1007/s12272-011-0819-3. Epub 2011 Sep 11.

PMID:
21910061
[PubMed - indexed for MEDLINE]
15.

Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.

Okamura H, Yoshida K, Ochiai K, Haneji T.

Bone. 2011 Sep;49(3):368-75. doi: 10.1016/j.bone.2011.06.004. Epub 2011 Jun 12.

PMID:
21683816
[PubMed - indexed for MEDLINE]
16.

Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.

Lee CH, Huang YL, Liao JF, Chiou WF.

Eur J Pharmacol. 2011 Oct 15;668(3):383-9. doi: 10.1016/j.ejphar.2011.06.059. Epub 2011 Jul 26.

PMID:
21806985
[PubMed - indexed for MEDLINE]
17.

The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation.

Jeong BC, Lee YS, Park YY, Bae IH, Kim DK, Koo SH, Choi HR, Kim SH, Franceschi RT, Koh JT, Choi HS.

J Biol Chem. 2009 May 22;284(21):14211-8. doi: 10.1074/jbc.M808345200. Epub 2009 Mar 26.

PMID:
19324883
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation.

McLachlan E, Plante I, Shao Q, Tong D, Kidder GM, Bernier SM, Laird DW.

J Bone Miner Res. 2008 Jun;23(6):928-38. doi: 10.1359/jbmr.080217.

PMID:
18269311
[PubMed - indexed for MEDLINE]
19.
20.

Modulation of connexin43 alters expression of osteoblastic differentiation markers.

Li Z, Zhou Z, Saunders MM, Donahue HJ.

Am J Physiol Cell Physiol. 2006 Apr;290(4):C1248-55. Epub 2005 Nov 30.

PMID:
16319124
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk